However, in certain constellations when CAA cannot be diagnosed but is highly suspected, other less invasively obtainable biomarkers such as CSF [41,42] and the assessment of amyloids and tau or amyloid PET [43] can be helpful. The gene discussed is MAPT; the disease is amyloidosis.